Methodological issues arising from systematic reviews of the evidence of safety of vaccines

被引:16
作者
Price, D [1 ]
Jefferson, T [1 ]
Demicheli, V [1 ]
机构
[1] Cochrane Vaccines Field & Hlth Reviews Ltd, Cochrane Ctr, Oxford OX2 7LG, England
关键词
vaccine safety; adverse event; systematic review; methodology;
D O I
10.1016/j.vaccine.2004.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adaptations to the recognized methods of systematic reviewing are required when addressing questions about safety, particularly about rare and/or long-term serious adverse events. Conducting a systematic review of vaccine safety requires the implementation of novel strategies for locating studies, the use of experimental instruments to assess the quality of non-randomized studies, and the employment of pooling methods for non-randomized data, where appropriate. Standardizing both the indexing of adverse event data on electronic libraries and their reporting would improve the potential of systematic reviews of vaccine to draw accurate conclusions about the safety of a vaccine. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2080 / 2084
页数:5
相关论文
共 23 条
[1]  
[Anonymous], 2002, Cochrane Reviewers Handbook 415
[2]  
BAGETT R, 1999, P 7 ANN COCHR C ABST
[3]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[4]  
BRADFORDHILL A, 1965, P ROY SOC MED, V58, P295
[5]  
*BRIGHT COLL, SETT STAND VACC SAF
[6]   Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments [J].
Chalmers, I .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (05) :1156-1164
[7]  
CHALMERS I, 2001, SYSTEMATIC REV HLTH, pR12
[8]  
Davey-Smith G., 2008, SYSTEMATIC REV HLTH
[9]   Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials [J].
Derry S. ;
Loke Y.K. ;
Aronson J.K. .
BMC Medical Research Methodology, 1 (1) :1-6
[10]  
DINNES J, 2000, P 3 S SYST REV UK OX